$0.6310
-0.0102-1.59%
Ult. Agg.: Oct 2, 7:57 PM
$0.6499
0.00871.36%
Oncolytics Biotech (ONCY) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.07 | $-0.07 | $-0.07 | $-0.06 |
| Actual | $-0.08 | $-0.06 | $-0.09 | $-0.10 |
| Surprise | -14.3% | +14.3% | -28.6% | -66.7% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.07 | $-0.08 | $-0.04 | $-0.05 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $-0.08 | $-0.07 | -14.3 % |
| Q1 | May 14, 2026 | $-0.06 | $-0.07 | 14.3 % |
| Q4 | Mar 30, 2026 | $-0.09 | $-0.07 | -28.6 % |
| Q3 | Nov 12, 2025 | $-0.10 | $-0.06 | -66.7 % |